Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,072.00    106.00 (5.39%)
Bid:
2,058.00
Ask:
2,072.00
Spread: 14.00 (0.68%)
Market Cap: £1.38b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

22 Sep 2010 14:49

RNS Number : 1319T
Genus PLC
22 September 2010
Β 

22 September 2010

Β 

Genus plc

Β 

('Genus' or 'the Company')

Β 

Director/PDMR Shareholding

Β 

Β 

Genus announces that conditional nil-cost share options were granted under the Genus 2004 Performance Share PlanΒ ("the Plan")Β todayΒ toΒ Richard Wood, Chief Executive, as toΒ 57,631 ordinaryΒ sharesΒ of 10 pence each in theΒ CompanyΒ ("Ordinary Shares"). These options are subject to performance conditions which relate to growth in the Company's earnings per share over a three year period and which trigger vesting on an incremental basis.

Β 

Genus further announces that of 154,639 Ordinary Shares that vested today in favour of Richard Wood, Chief Executive, under the Plan, 154,639 Ordinary Shares were today sold on behalf of Richard Wood at a price ofΒ 770Β pence per Ordinary Share.

Β 

Richard Wood's direct shareholding in the Company stands atΒ 60,856Β Ordinary Shares which representsΒ 0.102%Β of the issued share capital of the Company which is currentlyΒ 59,678,535 Ordinary Shares. In addition, he remains the beneficial owner of 195,457 conditional nil-cost optionsΒ under the Plan.

Β 

Genus also announces that ofΒ 34,364Β Ordinary SharesΒ that vested today in favour of Ian Biggs, Head of Global Product & Business Strategy, under the Plan,Β 34,364Β Ordinary Shares were today sold on behalf ofΒ Ian BiggsΒ at a price ofΒ 770Β pence per Ordinary Share. Ian Biggs'Β direct shareholding in the Company stands atΒ 3,375Β Ordinary Shares which representsΒ 0.006%Β of the issued share capital of the Company. In addition, he remains the beneficial owner ofΒ 109,530Β conditional nil-cost optionsΒ under the Plan.

Β 

OfΒ 33,505Β Ordinary Shares that vested today in favour of Thomas Philip Acton, Chief Operating Officer of Europe & The Far East, under the Plan, 33,505Β Ordinary Shares were today sold on behalf of Thomas Philip Acton at a price ofΒ 770Β pence per Ordinary Share.

Thomas Philip Acton'sΒ direct shareholding in the Company stands atΒ 21,104Β Ordinary Shares which representsΒ 0.035%Β of the issued share capital of the Company. In addition, he remains the beneficial owner of 103,084 conditional nil-cost optionsΒ under the Plan.

Β 

Of 17,182 Ordinary Shares that vested today in favour of Ian Farrelly, Group Company Secretary & General Counsel, under the Plan, 17,182 Ordinary Shares were today sold on behalf of Ian Farrelly at a price ofΒ 770Β pence per Ordinary Share. Ian Farrelly has no direct shareholding in the Company. He remains the beneficial owner of 75,018 conditional nil-cost optionsΒ under the Plan.

Β 

Β 

For further information please contact:

Β 

Cara Crichton

Company Secretarial Assistant

Genus plc

Β 

Tel: 01256 345996

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSUUSORRWAKUAR
Date   Source Headline
31st Jul 20122:00 pmRNSBlocklisting Interim Review
31st Jul 20122:00 pmRNSTotal Voting Rights
31st Jul 20127:00 amRNSJoint Venture in China
4th Jul 20127:00 amRNSPre-Close Trading Statement
15th May 20124:09 pmRNSHolding(s) in Company
15th May 20124:08 pmRNSHolding(s) in Company
3rd May 20127:00 amRNSInterim Management Statement and Strategy Update
30th Apr 20122:00 pmRNSTotal Voting Rights
30th Mar 20122:00 pmRNSTotal Voting Rights
14th Mar 20122:00 pmRNSDirector/PDMR Shareholding
29th Feb 20122:00 pmRNSTotal Voting Rights
27th Feb 20124:25 pmRNSHolding(s) in Company
21st Feb 20123:16 pmRNSHolding(s) in Company
21st Feb 20122:30 pmRNSDirector/PDMR Shareholding
21st Feb 20127:00 amRNSInterim Results
31st Jan 20122:00 pmRNSBlocklisting Interim Review
31st Jan 201210:44 amRNSNotice of Results
16th Jan 20123:49 pmRNSHolding(s) in Company
4th Jan 20127:00 amRNSSenior Management Changes
30th Dec 201112:00 pmRNSTotal Voting Rights
30th Nov 20112:00 pmRNSTotal Voting Rights
10th Nov 201112:51 pmRNSResult of AGM
10th Nov 20117:00 amRNSAGM and Interim Management Statement
31st Oct 20112:00 pmRNSTotal Voting Rights
27th Oct 20112:00 pmRNSAnnual Information Update
11th Oct 201111:39 amRNSAnnual Report and Annual General Meeting
30th Sep 20112:44 pmRNSTotal Voting Rights
22nd Sep 20112:33 pmRNSHolding(s) in Company
20th Sep 20113:08 pmRNSAdditional Listing
20th Sep 20113:07 pmRNSDirector/PDMR Shareholding
9th Sep 201111:00 amRNSDirector/PDMR Shareholding
6th Sep 20117:00 amRNSPreliminary Results
31st Aug 20112:00 pmRNSTotal Voting Rights
29th Jul 20112:00 pmRNSBlocklisting Interim Review
29th Jul 20112:00 pmRNSTotal Voting Rights
4th Jul 20117:00 amRNSPre-close Trading Statement
25th May 20117:00 amRNSCEO Retirement and Appointment of Successor
12th May 20112:08 pmRNSHolding(s) in Company
11th May 20117:00 amRNSInterim Management Statement
28th Apr 20112:00 pmRNSTotal Voting Rights
31st Mar 20112:00 pmRNSTotal Voting Rights
10th Mar 20115:56 pmRNSHolding(s) in Company
9th Mar 201111:00 amRNSDirector Shareholding
28th Feb 20112:37 pmRNSTotal Voting Rights
22nd Feb 20117:00 amRNSInterim Results
31st Jan 20112:00 pmRNSBlocklisting Interim Review
31st Jan 20112:00 pmRNSTotal Voting Rights
27th Jan 20113:57 pmRNSNotice of Results
21st Jan 20113:36 pmRNSHolding(s) in Company
30th Nov 20102:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.